ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 704533 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 704533; 2) Community: the network communities that were significantly associated with the response to NSC 704533; 3) Molecule: the relationships between components within communities and NSC 704533; 4) MDR: the compounds that were significantly associated with the NSC 704533.

NSC Compound Enrichment Correlation
NSC 315844 2(1H)-Pyrimidinone, 1-(2,5-dihydro-5-oxo-2-furanyl)-5-fluoro-4-methoxy- 0.0454469012959173 0.084874751
NSC 31709 Quinolinium, 2-[2-(2,5-dimethyl-1-pentyl-1H-pyrrol-3-yl)ethenyl]-1,6-dimethyl-, chloride 0.0454469012959173 0.041713464
NSC 320951 Bishelenalinyl malonate 0.0454469012959173 0.072873612
NSC 344505 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- 0.0454469012959173 0.52520691
NSC 371488 9-(3,4-dichlorophenyl)-2,7-bis((dimethylamino)methyl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione, dihydrochloride 0.0454469012959173 0.090238859
NSC 606498 Camptothecin Derivative 0.0454469012959173 0.56172351
NSC 609699 Topotecan hydrochloride 0.0454469012959173 0.64875639
NSC 610459 Camptothecin Derivative 0.0454469012959173 0.65492969
NSC 624659 ANTINEOPLASTIC-624659 0.0454469012959173 0.12674836
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0454469012959173 0.18342973
Total:70  Current:60    [First] [Prev] [Next] [Last]